Related Experiment Video
Updated: Jun 25, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Centrosome-associated regulators of the G(2)/M checkpoint as targets for cancer therapy
Yingmei Wang1, Ping Ji, Jinsong Liu
1Tianjin General Hospital, Tianjin Medical University, Tianjin, PR China. yingmeiwang@gmail.com
Abstract:
In eukaryotic cells, control mechanisms have developed that restrain cell-cycle transitions in response to stress. These regulatory pathways are termed cell-cycle checkpoints. The G(2)/M checkpoint prevents cells from entering mitosis when DNA is damaged in order to afford these cells an opportunity to repair the damaged DNA before propagating genetic defects to the daughter cells. If the damage is irreparable, checkpoint signaling might activate pathways that lead to apoptosis. Since alteration of cell-cycle control is a hallmark of tumorigenesis, cell-cycle regulators represent potential targets for therapy. The centrosome has recently come into focus as a critical cellular organelle that integrates G(2)/M checkpoint control and repairs signals in response to DNA damage. A growing number of G(2)/M checkpoint regulators have been found in the centrosome, suggesting that centrosome has an important role in G(2)/M checkpoint function. In this review, we discuss centrosome-associated regulators of the G(2)/M checkpoint, the dysregulation of this checkpoint in cancer, and potential candidate targets for cancer therapy.
Insights
Cell-cycle checkpoints, like the G(2)/M checkpoint, prevent mitosis with DNA damage. The centrosome plays a key role in this process and offers potential cancer therapy targets.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Cell-cycle checkpoints are crucial regulatory pathways in eukaryotic cells that respond to stress.
- The G(2)/M checkpoint specifically prevents entry into mitosis if DNA damage is detected, allowing for repair.
- Dysregulation of cell-cycle control is a common feature of cancer, making cell-cycle regulators attractive therapeutic targets.
Purpose of the Study:
- To review the role of centrosome-associated regulators in the G(2)/M checkpoint.
- To discuss the implications of G(2)/M checkpoint dysregulation in cancer.
- To identify potential therapeutic targets for cancer treatment.
Main Methods:
- Literature review focusing on centrosome-associated G(2)/M checkpoint regulators.
- Analysis of the role of these regulators in DNA damage response and repair.
- Examination of the link between checkpoint dysregulation and tumorigenesis.
Main Results:
- The centrosome is increasingly recognized as a critical organelle integrating G(2)/M checkpoint control and DNA damage signaling.
- Numerous G(2)/M checkpoint regulators have been localized to the centrosome, highlighting its functional importance.
- Alterations in these centrosome-associated regulators are implicated in the progression of various cancers.
Conclusions:
- Centrosome-associated proteins are vital for proper G(2)/M checkpoint function.
- The centrosome's role in cell-cycle regulation presents promising avenues for novel cancer therapies.
- Targeting centrosome-mediated G(2)/M checkpoint pathways could offer new strategies for cancer treatment.
More Related Videos
Related Concept Videos
Negative Regulator Molecules
Inhibition of Cdk Activity
Inhibition of CDK Activity
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
The Cell Cycle Control System
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...

